ArticleJournal of conservative dentistry and endodontics2026
Biocompatibility of carbazochrome sodium sulfonate on human dental pulp stem cells: An
Article in Journal of conservative dentistry and endodontics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The effectiveness of vital pulp therapy (VPT) depends on achieving adequate hemostasis and preservation of pulp vitality. Carbazochrome sodium sulfonate (CSS), a synthetic hemostatic agent considered to be safe in systemic use; however, its local effect on human dental pulp stem cells (HDPSCs) remains unexplored. This preliminary Materials and Methods: HDPSCs were derived from healthy permanent teeth and maintained under standard culture conditions. The cells were distributed into control group (0.1% dimethyl sulfoxide serving as the vehicle) and experimental groups treated with CSS at 0.1 μM, 1 μM, 5 μM, and 10 μM. Cellular responses were assessed at 24, 48, and 72 h following exposure. The 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide assay was utilized to determine cell viability, and adhesion was calculated by measuring the number of nonadherent cells. Data were analyzed using the one-way ANOVA followed by Tukey's Results: Lower concentrations of CSS (0.1 μM and 1 μM) demonstrated viability and adhesion values similar to the control group. In contrast, higher concentrations (5 μM and 10 μM) showed a gradual decrease in both parameters over time ( Conclusion: Based on the findings from this study, lower concentrations of CSS were well tolerated with HDPSCs, whereas higher concentrations negatively influenced both viability and adhesion. Hence, precise concentration control is essential for the use of CSS in VPT.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.